Executive interview – Aptahem at DNB NALS conference

Published on 19 December 2019
 

Aptahem‘s CEO, Mikael Lindstam joined Edison at DNB’s 4th North American Life Science conference to discuss highlights from 2019 and what to expect in 2020.

Share this with friends and colleagues

You may also be interested in these

lavie_bio_thumb.jpg

Executive interview – Lavie Bio

Healthcare
14 January 2020

Executive interview – Abacus Health Products

Healthcare
9 January 2020

Executive interview – Cereno Scientific at DNB NALS conference

Healthcare
19 December 2019

Executive interview – Orexo at DNB NALS conference

Healthcare
19 December 2019

Cookies

This site uses cookies: Find out more.